These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15777203)

  • 21. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
    Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proinflammatory and anti-inflammatory cytokines in gingival crevicular fluid and serum of patients with rheumatoid arthritis and patients with chronic periodontitis.
    Cetinkaya B; Guzeldemir E; Ogus E; Bulut S
    J Periodontol; 2013 Jan; 84(1):84-93. PubMed ID: 22414257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis.
    Wolf RE; Brelsford WG; Hall VC; Adams SB
    J Rheumatol; 1992 Apr; 19(4):524-8. PubMed ID: 1593571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pro- and anti-inflammatory cytokines in rheumatoid arthritis.
    Isomäki P; Punnonen J
    Ann Med; 1997 Dec; 29(6):499-507. PubMed ID: 9562516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis.
    Paulos CM; Turk MJ; Breur GJ; Low PS
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1205-17. PubMed ID: 15094216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].
    Bläss S; Engel JM; Burmester GR
    Z Rheumatol; 2001 Feb; 60(1):1-16. PubMed ID: 11263010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current understanding of rheumatoid arthritis therapy.
    Colmegna I; Ohata BR; Menard HA
    Clin Pharmacol Ther; 2012 Apr; 91(4):607-20. PubMed ID: 22357455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis.
    Qi J; Ye X; Ren G; Kan F; Zhang Y; Guo M; Zhang Z; Li D
    Mol Immunol; 2014 Feb; 57(2):59-65. PubMed ID: 24091292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
    McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
    J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of IL-15 in rheumatoid arthritis.
    Yang XK; Xu WD; Leng RX; Liang Y; Liu YY; Fang XY; Feng CC; Li R; Cen H; Pan HF; Ye DQ
    Hum Immunol; 2015 Nov; 76(11):812-8. PubMed ID: 26429323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shift in Th1 (IL-2 and IFN-gamma) and Th2 (IL-10 and IL-4) cytokine mRNA balance within two new histological main-types of rheumatoid-arthritis (RA).
    Ruschpler P; Stiehl P
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):285-93. PubMed ID: 12030433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
    Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
    Front Immunol; 2018; 9():2228. PubMed ID: 30319663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selected cytokine pathways in rheumatoid arthritis.
    Noack M; Miossec P
    Semin Immunopathol; 2017 Jun; 39(4):365-383. PubMed ID: 28213794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel therapies for rheumatoid arthritis.
    Tremoulet AH; Albani S
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1427-41. PubMed ID: 17040201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
    Meroni PL; Valesini G
    BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis.
    Li X; Yuan FL; Lu WG; Zhao YQ; Li CW; Li JP; Xu RS
    Biochem Biophys Res Commun; 2010 Jun; 397(2):131-5. PubMed ID: 20513356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of tacrolimus for joint destruction in rheumatoid arthritis].
    Tanaka Y; Suzuki K; Saito K
    Clin Calcium; 2007 Apr; 17(4):593-9. PubMed ID: 17404490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
    Symons JA; Wood NC; Di Giovine FS; Duff GW
    J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.